Fingerprint
Dive into the research topics of 'KEYNOTE-676: Phase III study of BCG and pembrolizumab for persistent/recurrent high-risk NMIBC'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
KEYNOTE-676: Phase III study of BCG and pembrolizumab for persistent/recurrent high-risk NMIBC
Ashish M. Kamat, Neal Shore, Noah Hahn, Shaheen Alanee, Hiroyuki Nishiyama, Shahrokh Shariat, Kijoeng Nam, Ekta Kapadia, Tara Frenkl, Gary Steinberg
Research output: Contribution to journal › Review article › peer-review
7
Scopus
citations